BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31446212)

  • 1. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
    Yuan P; Huang S; Bao FC; Cao JL; Sheng HX; Shi L; Lv W; Hu J
    Eur J Cancer; 2019 Oct; 120():10-19. PubMed ID: 31446212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.
    Spiegl-Kreinecker S; Lötsch D; Ghanim B; Pirker C; Mohr T; Laaber M; Weis S; Olschowski A; Webersinke G; Pichler J; Berger W
    Neuro Oncol; 2015 Sep; 17(9):1231-40. PubMed ID: 25681309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
    Ko E; Seo HW; Jung ES; Kim BH; Jung G
    Oncotarget; 2016 Jan; 7(1):684-99. PubMed ID: 26575952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients.
    Giunco S; Padovan M; Angelini C; Cavallin F; Cerretti G; Morello M; Caccese M; Rizzo B; d'Avella D; Puppa AD; Chioffi F; De Bonis P; Zagonel V; De Rossi A; Lombardi G
    ESMO Open; 2023 Jun; 8(3):101570. PubMed ID: 37230028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Significance of TERT Locus Polymorphism (rs36115365) in Surgically Resected Non-Small Cell Lung Cancer.
    Lee DH; Jung SJ; Park WJ; Heo YR; Lee JH
    Ann Clin Lab Sci; 2020 Sep; 50(5):645-649. PubMed ID: 33067210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.
    Nencha U; Rahimian A; Giry M; Sechi A; Mokhtari K; Polivka M; Schmitt Y; Di Stefano AL; Alentorn A; Labussière M; Sanson M
    J Neurooncol; 2016 Feb; 126(3):441-6. PubMed ID: 26608520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A TERT-CLPTM1 locus polymorphism (rs401681) is associated with EGFR mutation in non-small cell lung cancer.
    Lee DH; Heo YR; Park WJ; Lee JH
    Pathol Res Pract; 2017 Nov; 213(11):1340-1343. PubMed ID: 29033187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
    Gao K; Li G; Qu Y; Wang M; Cui B; Ji M; Shi B; Hou P
    Oncotarget; 2016 Feb; 7(8):8712-25. PubMed ID: 26556853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
    Wei R; Cao L; Pu H; Wang H; Zheng Y; Niu X; Weng X; Zhang H; Favus M; Zhang L; Jia W; Zeng Y; Amos CI; Lu S; Wang HY; Liu Y; Liu W
    Clin Cancer Res; 2015 Nov; 21(22):5173-5180. PubMed ID: 26149460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
    Labussière M; Di Stefano AL; Gleize V; Boisselier B; Giry M; Mangesius S; Bruno A; Paterra R; Marie Y; Rahimian A; Finocchiaro G; Houlston RS; Hoang-Xuan K; Idbaih A; Delattre JY; Mokhtari K; Sanson M
    Br J Cancer; 2014 Nov; 111(10):2024-32. PubMed ID: 25314060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible association of the TERT promoter polymorphisms rs2735940, rs7712562 and rs2853669 with diabetes mellitus in obese elderly Polish population: results from the national PolSenior study.
    Gutmajster E; Chudek J; Augusciak-Duma A; Szwed M; Szybalska A; Mossakowska M; Puzianowska-Kuznicka M; Wiecek A; Sieron AL
    J Appl Genet; 2018 Aug; 59(3):291-299. PubMed ID: 29938393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population.
    Yoo SS; Do SK; Choi JE; Lee SY; Lee J; Cha SI; Kim CH; Park JY
    J Korean Med Sci; 2015 Oct; 30(10):1423-8. PubMed ID: 26425038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of EGFR 1 Gene Alteration and their Association with Lung Adenocarcinoma Patients.
    Ali Beg MM; Fahdil SR; Yadav P; Shukla KK; Mohan A; Saxena A
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):825-830. PubMed ID: 30912007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.
    Hsu CP; Hsu NY; Lee LW; Ko JL
    Eur J Cancer; 2006 Jul; 42(10):1466-74. PubMed ID: 16737810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.
    Yuan P; Cao JL; Abuduwufuer A; Wang LM; Yuan XS; Lv W; Hu J
    PLoS One; 2016; 11(1):e0146803. PubMed ID: 26799744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere length assessment and molecular characterization of TERT gene promoter in periampullary carcinomas.
    Gregório C; Thakur S; Camara Rivero R; Márcia Dos Santos Machado S; Cuenin C; Carreira C; White V; Cree IA; Vukojevic K; Glavina Durdov M; Bersch Osvaldt A; Ashton-Prolla P; Herceg Z; Talukdar FR
    Gene; 2023 Jul; 873():147460. PubMed ID: 37150235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT promoter mutations in clear cell renal cell carcinoma.
    Hosen I; Rachakonda PS; Heidenreich B; Sitaram RT; Ljungberg B; Roos G; Hemminki K; Kumar R
    Int J Cancer; 2015 May; 136(10):2448-52. PubMed ID: 25331263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.
    Xing YL; Liu F; Li JF; Lin JC; Zhu GD; Li M; Zhang CR; Niu YY
    J Clin Lab Anal; 2016 Nov; 30(6):1071-1077. PubMed ID: 27154632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
    Batista R; Cruvinel-Carloni A; Vinagre J; Peixoto J; Catarino TA; Campanella NC; Menezes W; Becker AP; de Almeida GC; Matsushita MM; Clara C; Neder L; Viana-Pereira M; Honavar M; Castro L; Lopes JM; Carvalho B; Vaz RM; Máximo V; Soares P; Sobrinho-Simões M; Reis RM; Lima J
    Int J Cancer; 2016 Jul; 139(2):414-23. PubMed ID: 26914704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.